The EVAR Center

Filter Your Results

 

News

 

Post-EVAR Surveillance Considerations

Frederico Bastos Gonçalves, MD, PhD

March 2017—Evaluating and stratifying risks based on currently available data.

Vascular Pioneer Edward B. Diethrich, MD, 1935–2017

February 28, 2017 -- Edward B. Diethrich, MD, a pioneer in noninvasive cardiovascular disease diagnosis and innovative surgical and minimally invasive treatments, succumbed to…

Aortica’s FEVAR Case-Planning Software Used for Physician-Modified Grafts to Treat Juxtarenal AAA

February 28, 2017 -- Benjamin W. Starnes, MD, Chief of Vascular Surgery at the University of Washington in Seattle, Washington, recently announced midterm results fr…

Endologix’s Ovation LUCY Study Completes Patient Enrollment

February 14, 2017 -- Endologix, Inc. announced that it has completed patient enrollment for the LUCY (Evaluation of FemaLes who are Underrepresented Candidates for Abdominal A…

German Registry Data Evaluated for Trends in Patient Safety of AAA Repair

February 7, 2017 -- German registry data on 36,594 procedures to repair nonruptured abdominal aortic aneurysms (AAA) were published by Matthias Trenner, MD, et al online …

Lombard Medical Launches IntelliFlex LP Delivery System in Japan

February 7, 2017 -- Lombard Medical, Inc. announced the Japanese launch of the IntelliFlex LP low-profile delivery system for the Aorfix endovascular stent graft for the treat…

Midterm Results Reported for Physician-Modified Endovascular Grafts to Treat Juxtarenal Aortic Aneurysms

February 1, 2017 -- In the Journal of Vascular Surgery (JVS), Benjamin W. Starnes, MD, et al published the midterm results from an ongoing physician-sponsored investigational …

CE Mark Reinstated for Endologix's AFX and AFX2 Endovascular AAA Systems

January 25, 2017 -- Endologix, Inc. announced that it has received notice from its Notified Body in the European Union that the CE Mark for the AFX and AFX2 end…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.